COVID-19: 90-Day Refills May Strain Supply Chain – Specialty Pharmacy Continuum

According to the article:

“Across the country, pharmacies have been seeing a significant uptick in patients seeking to extend 30-day prescriptions to 90 days to ensure access to their medications amid the growing COVID-19 crisis. While stakeholders say they have been able to meet these requests, several indicate that it’s only a matter of time before the supply chain buckles under these new pressures.”

Read the source article:  COVID-19: 90-Day Refills May Strain Supply Chain – Specialty Pharmacy Continuum


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights

According to the article:

“Blockchain startup Mediledger has published the results of its FDA blockchain pilot for the pharmaceutical supply chain. Numerous separate groups applied to the FDA and ran pilots for the Drug Supply Chain Security Act (DSCSA) 2023 milestone for package-level tracing, with this being one of the largest groups. Mediledger’s participants included all three major U.S. wholesalers, seven out of ten of the world’s largest pharmaceutical companies, massive dispensers Walgreens and Walmart, as well as logistics firms such as FedEx.”

Read the source article:  Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Coronavirus and the Automotive and Pharmaceutical Supply Chains – Logistics Viewpoint

According to the article:

Another industry that is feeling the impact of the coronavirus is the pharmaceutical industry. The average buffer inventory for the pharmaceutical industry is between three and six months. However, this does not tell the full story. Gaurav mentioned that China is responsible for producing 40 percent of the active pharmaceutical ingredients (APIs) for the pharmaceutical world. Additionally, China supplies 80 percent of key starting materials (KSM’s), which are the chemicals in APIs, to India. Put together, this represents 70 percent of all APIs across the world.

Read the source article:  Coronavirus and the Automotive and Pharmaceutical Supply Chains – Logistics Viewpoint


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Board-Approved! Three (3) California Designated Representative Online Training Programs

SkillsPlus International Inc. proudly offers the largest selection of Board-approved California Designated Representative online training courses. Earns a Board-recognized training affidavit. More than 6,000 students trained!

California Designated Representative Online Training for Drug/Device Wholesalers

California Designated Representative Online Training for 3PL (third-party logistics providers)

California Designated Representative Online Training for Reverse Distributors


Go to DREprof.com: The Designated Representative and Exemptee Training Website

DHL Supply Chain Invests $150 Million to Expand Pharmaceutical and Medical Device Distribution Network in the U.S. – PRweb.com

“DHL Supply Chain, the Americas leader in contract logistics and part of Deutsche Post DHL Group, is expanding its pharmaceutical and medical device distribution network by 40 percent this year with an investment of $150 million. With the ultimate goal of bringing critical healthcare products closer to trade partners and patients, DHL Supply Chain plans for nine new sites by the end of 2019. The investment includes costs to invest in new buildings and technology, as well as the fit-out and start-up of new or expanded operations.”

Read the full source article:  DHL Supply Chain Invests $150 Million to Expand Pharmaceutical and Medical Device Distribution Network in the U.S. – PRweb.com


#CaliforniaDesignatedRepresentative #CaliforniaDesRep

Go to DREprof.com: The Designated Representative and Exemptee Training Website

Theft and Sabotage in the Supply Chain is Big Business – HealthcarePackaging.com

“Supply chain theft is estimated at $35-40 billion per year in the US, and today’s threats to the commercial supply chain are different than those of the past. Logistics companies are perfect targets, and those that aren’t aware of the changes are more likely to fall prey.”

“Brandman discussed why theft-related loss is getting worse, and said that the value of the product plus a low risk factor, lax security and an inadequate criminal justice system equals high gain, low risk. Plus, says Brandman, the internet combined with small parcel delivery service make it easy to distribute stolen goods. Thieves – often internal – who work together can result in significant loss to the company.”

Read the full article:  Theft and Sabotage in the Supply Chain is Big Business – HealthcarePackaging.com


Go to DREprof.com: The Designated Representative and Exemptee Training Website

How DSCSA Changes the Licensing Landscape | Pharmaceutical Executive


California Designated Representative Training Course for 3PL (approved by the California State Board of Pharmacy)


The impact of new 3PL licensing

The big license aftershock following the DSCSA earthquake came when the FDA redefined the parameters of 3PL companies. Before the passage of DSCSA, 3PL companies could be licensed as a wholesaler. Now, that’s no longer the case.”

Read the entire article to learn how the DSCSA impacts third-party logistics providers (3PLs).

Read the complete article (source): How DSCSA Changes the Licensing Landscape | Pharmaceutical Executive


Go to DREprof.com: The Designated Representative and Exemptee Training Website

How Well Do You Understand Your Cargo Theft Threats? | iwla1891

The Threat of Cargo Thefts – Does this affect third party logistics (3PL)?

“Cargo theft affects businesses across the globe. Beyond the direct cost of the stolen goods, missing cargo can have far-reaching supply chain implications. Threats to your company’s cargo can vary by commodity type, region and even day of the week. Understanding your product’s susceptibility to theft and developing appropriate strategies to reduce it can help protect your cargo and your business.”

Read the full article – Source: How Well Do You Understand Your Cargo Theft Threats? | iwla1891


Go to DREprof.com: The Designated Representative and Exemptee Training Website

New ATA report takes a deep dive into the ongoing truck driver shortage – Logistics Management

“So, what about those future numbers? You may want to cover your eyes, as they are not pretty. According to the ATA, the driver shortage is projected to hit 50,000 by the end of 2017, with the possibility, if things remain the same, that the number could exceed 174,000 by 2026.”

Source: New ATA report takes a deep dive into the ongoing truck driver shortage – Logistics Management


Go to DREprof.com: The Designated Representative and Exemptee Training Website

FDA Clarifies DSCSA Entities And Trading Partners

Entities & Trading Partners Defined Under The DSCSA

“The Food and Drug Administration (FDA or the Agency) is issuing this guidance to assist industry and State and local governments in understanding how to categorize the entities in the drug supply chain in accordance with the Drug Supply Chain Security Act (DSCSA). DSCSA establishes product tracing requirements for certain trading partners in the drug supply chain, including manufacturers, repackagers, wholesale distributors, and dispensers. DSCSA also requires that trading partners of manufacturers, wholesale distributors, dispensers, and repackagers must meet the applicable requirements for being “authorized trading partners.” DSCSA also requires FDA to issue regulations that establish Federal standards for the licensing of wholesale drug distributors (WDDs) and third-party logistics providers (3PLs). The Agency is currently drafting these regulations. This guidance, when finalized, will explain FDA’s current thinking on how licensing and certain other requirements apply to entities that may be considered trading partners in the drug supply chain.

This guidance is intended to (1) assist industry and State and local governments in understanding the applicability of DSCSA requirements to the various types of entities that take part in the distribution of prescription drugs in the United States, and (2) help clarify for industry whether they are engaged in activities that require licensure and annual reporting, as well as other requirements related to being an authorized trading partner in the drug supply chain. The guidance does not address all requirements described in DSCSA, but is limited to describing the activities that would determine what type of trading partner an entity may be and the applicable requirements under DSCSA.”

Source:
Identifying Trading Partners Under the Drug Supply Chain Security Act – Guidance for Industry – DRAFT GUIDANCE (PDF)


Go to DREprof.com: The Designated Representative and Exemptee Training Website